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Abstract
Background: Hydrogen sulfide (H2S), a novel gaseous mediator, has been recognized as an important neuromodulator
and neuroprotective agent in the nervous system. The present study was undertaken to study the effects of exogenous
H2S on ischemia/reperfusion (I/R) injury of spinal cord and the underlying mechanisms.
Methods: The effects of exogenous H2S on I/R injury were examined by using assessment of hind motor function,
spinal cord infarct zone by Triphenyltetrazolium chloride (TTC) staining. Autophagy was evaluated by expressions of
Microtubule associated protein 1 light chain 3 (LC3) and Beclin-1 which were determined by using Quantitative
Real-Time PCR and Western blotting, respectively.
Results: Compared to I/R injury groups, H2S pretreatment had reduced spinal cord infarct zone, improved hind
motor function in rats. Quantitative Real-Time PCR or Western blotting results showed that H2S pretreatment also
downregulated miR-30c expression and upregulated Beclin-1 and LC3II expression in spinal cord. In vitro, miR-30c
was showed to exert negative effect on Beclin-1 expression by targeting its 3’UTR in SY-SH-5Y cells treated with
Oxygen, Glucose Deprivation (OGD). In rat model of I/R injury, pretreatment of pre-miR-30c or 3-MA (an inhibitor
for autophagy) can abrogated spinal cord protective effect of H2S.
Conclusion: H2S protects spinal cord and induces autophagy via miR-30c in a rat model of spinal cord
hemia-reperfusion injury.
Keywords: Autophagy, Beclin-1, miR-30c, Microtubule associated protein 1 light chain 3 (LC3), Oxygen glucose
deprivation (OGD)
Background
Ischemia/reperfusion (I/R) injury of the spinal cord is a
dynamic process that frequently occurs during a variety
of clinical situations such as thoracoabdominal aortic
surgery or spinal cord injury [1]. Due to complicated
pathogenic factor, such as, membrane permeability vari-
ation, fluid and electrolyte disorders, lipid oxidation, it is
difficult to achieve effective treatment for spinal cord in-
jury induced by I/R [2].
Hydrogen sulfide (H2S), endogenously derived from L-
cysteine in several organs, such as brain, heart, kidney and
liver [3], has been regarded as the third gasotransmitter
and endogenous neuromodulator and plays multiple roles
in the central nervous system under physiological and
pathological states, especially in secondary neuronal in-
jury. For example, H2S has been reported to protect brain
from I/R injury through maintaining mitochondrial func-
tion, inhibiting proinflammatory factors, neutralizing ROS
and reducing apoptosis [4]. However, the protective effect
of H2S on I/R injury of spinal cord has not been described.
Thus, we attempt to investigated the possible regulation
role of H2S on spinal cord I/R injury in vitro or in vivo.
The treatment with H2S could be achieved by inhalation
of H2S or administration of NaHS by intravenous injec-
tion. However, the study showed that it is difficult to con-
trol the concentration of inhaled H2S, which could result
in toxicity to animals [5]. Now, administration of NaHS by* Correspondence: LeiLi1100@163.com1Department of Orthopedics, Shengjing Hospital of China Medical University,
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intravenous injection becomes the common treatment for
I/R injury due to accuracy of concentration [6].
Micro-RNAs (miRNAs) are small noncoding regula-
tory RNAs of about 19–22 nucleotides that function as
translational inhibitor or mRNA degradation promoter
by binding to the 3’untranslated region of their target
mRNAs [7]. Recently, the biological roles of miRNA has
been considered to be extensively involved in the organic
I/R injury. For example, Bijkerk et al. miR-126 protect
renal ischemia/reperfusion injury by promoting vascular
integrity [8]. miR30a/p53 axis plays an important role in
triiodothyronine preventing cardiac I/R mitochondrial
impairment and cell loss [9]. Although no evidence for
miR-30c in spinal cord I/R injury, it has been proved to
be a neural protector by targeting brain derived neuro-
trophic factoras well as neurotrophin signaling and axon
guidance [10]. Based on miRNA being involved in H2S
protected against ischemic injury [11], we speculates that
miR-30c might be involved in H2S protecting I/R injury.
In addition, several miRNAs have also been reported
to be involved in autophagy modulation by regulating
the expression of autophagy-related genes [12]. Autoph-
agy, a regulated process of degradation and recycling of
cellular constituents, can participated in organelle turn-
over and the bioenergetic management of starvation of
spinal cord injury [13]. During autophagy, part of the cyto-
sol or entire organelles are sequestered into autophago-
somes. Autophagosomes ultimately fuse with lysosomes,
thereby generating single-membraned autophagolyso-
somes and degrading their content [14]. In experiments,
Beclin 1, the mammalian homologue of yeast Atg6, was
first described as a Bcl-2-interacting protein , and its me-
diated autophagy plays an important role in the regulation
of cell survival and death [15]. Additionally, microtubule-
associated protein 1 light chain 3 (LC3) were previously
found to promote autophagy by transforming LC3-I into
LC3-II. Notably, it has been reported the early and sus-
tained activation of autophagy after spinal cord injury [16]
and the change in expression of these autophagy-related
proteins has also been recognized in rat model of spinal
cord injury [17]. Recently, autophagy has been reported
to contributed to the protective effect of H2S against I/R
injury in hepar [18] and colon epithelial cells [19]. Thus,
we attempted to testify whether that occurs in regulation
effect of H2S on spinal cord I/R injury.
In this study, we established rat model of spinal cord
ischemia/reperfusion injury and investigated protective
effects of H2S and the underlying mechanism.
Methods
Chemicals and reagents
Ham’s F12 medium was obtained from Sigma-Aldrich
(St. Louis, USA). Fetal bovine serum (FBS) was from
Hyclone (Logan, UT, USA). Lipofectamine 2000 transfection
reagent was obtained from Invitrogen Life Technologies
(Grand Island, NY, USA). NaHS was purchased from
Sigma Aldrich (St. Louis, MO). Antibodies against Beclin-
1, LC3-I, LC3-II and β-Actin were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). The Deter-
gent Compatible (DC) Protein Assay kit was purchased
from Bio-Rad Laboratories (Hercules, CA, USA).
Animals and surgery
This study was performed in accordance with the National
Institute of Health guidelines for the use of experimen-
tal animals, and all animal protocols were approved by
the Institutional Animal Care and Use Committee of
China Medical University. Male Sprague-Dawley rats
(China Medical University Animal Center, Shenyang
China) weighting 300 to 350 g were used in the study.
The rats were housed in a temperature-controlled en-
vironment under a light-dark cycle condition with free
access to food and water.
Rat models of spinal cord ischemia-reperfusion injury
were performed. Briefly, rats were intraperitoneally anes-
thetized with 10 % chloral hydrate (300 mg/kg). Rectal
temperature was monitored and body temperature was
maintained at 37.0 ± 0.5 °C with an infrared heat lamp
and a heating pad. A 24-gauge catheter was inserted into
the tail artery to monitor the mean distal arterial pressure
(MDAP). Spinal cord ischemia was induced by inserting a
2 F-Fogarty balloon catheter (Edwards Life Science,
Shanghai, China) through the left femoral artery into the
proximal descending thoracic aorta. The distance between
the site of insertion to the proximal descending thoracic
aorta was approximately 11 cm. The balloon was inflated
with 0.05 ml of distilled water to induce spinal cord ische-
mia. The efficiency of the occlusion was evidenced by an
immediate and sustained loss of detectable pulse pressure
and a decrease in MDAP.
Twelve hours after ischemia, the balloon was deflated,
and spinal cord blood flow was restored. The arterial
catheters were then removed, the incisions were sutured.
The animals were cultured in appropriate environment
for recover. Bladder content was compressed manually
as required. Arterial blood samples were collected before
ischemia 1 h and 6 h after the beginning of reperfusion,
respectively.
Experimental protocol
The rats were randomly divided into three groups. The
sham group (n = 10) underwent the surgical procedure
but without aortic occlusion; The I/R injury group (n =
10) underwent the surgical procedure and was adminis-
tered with an equal volume of saline; The I/R + NaSH
group (n = 10) was intraperitoneally injected with NaSH
(30 umol/kg, dissolved in saline) 30 minutes before the
initiation of ischemia. Forty–eight hours after reperfusion,
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animals were anesthetized with 3 % halothane and eutha-
nized by transcardiac perfusion with 100 mL of 0.9 % sa-
line solution and 50 mL of 4 % paraformaldehyde in
phosphatebuffered saline (PBS).
Assessment of neurologic function
The hind limb function was scored by the means of the
Basso, Beattie, and Bresnahan (BBB) open-field locomotor
scale, which ranges from 0 (no detectable hind limb move-
ment) to 21 (normal hind limb locomotion) [20]. Before
surgery the rats were placed individually in a molded plastic
open field to ensure that all subjects consistently obtained a
maximum score of 21. BBB scores were recorded at 1, 6,
12, 24, and 48 hours in the acute phase after reperfusion by
five experienced investigators who had not conducted the
surgery and were unaware of the group treatments. The
final score for each animal was determined by averaging
the values from all investigators.
Staining with triphenyltetrazolium chloride
The ischemic infarct was exhibited by triphenyltetrazo-
lium chloride (TTC) staining and evaluated by computer-
aided image acquisition. Briefly, the I/R injured spinal cord
were harvested, and sliced into 2.0-mm transverse sec-
tions. The slices were incubated in 2 % TTC (dissolved in
PBS) for 30 minutes at 37 °C and then were stored in a
10 % formalin solution. Infarct areas were measured by
using NIH Image (National Institutes of Health, Bethesda,
Md) image analysis software, and data were represented as
the percentage of the infarct area in the total area of the
spinal cord section.
Quantitative Real-Time PCR
Total RNA was extracted from the spinal cord tissue or SY-
SH-5Y cells with the Trizol Reagent (Invitrogen, Carlsbad,
CA, USA), respectively. The mature miR-30(a–e), Beclin-1
mRNA and LC3 miRNA were quantified by using
Quantitative Real-Time PCR (Q-RT-PCR) assays with
fluorescent nucleic acid dye. Each sample (1 μg) was re-
verse-transcribed into cDNA by using the RealMasterMix
First Strand cDNA Synthesis Kit (Tiangen) according to
manufacture’s protocol. Real-time PCR was conducted by
using SYBR Premix ExTagTM (Takara) according to the
manufacturer’s protocols and performed in the Applied
Biosystems 7500 Real-time PCR system. The threshold
cycle (CT) is defined as the fractional cycle number at
which the fluorescence passes the fixed threshold. The
miRNA expression levels were normalized to U6 RNA
and the Beclin-1 and LC3 mRNA levels were normalized
to actin mRNA. All reactions were run in triplicate.
Cells and oxygen, glucose deprivation (OGD) treatment
SY-SH-5Y cell line, derived from human hippocampal
neurons, was obtained from Sigma-Aldrich (St. Louis,
USA) and was cultured in Ham’s F12 medium including
EMEM (EBSS) (1:1), 2 mM Glutamine, 1 % Non Essen-
tial Amino AcidsNEAA, 15 % Foetal Bovine Serum FBS/
FCS at 37 °C. The neuronal injury during ischemia is
due to a reduction in the supplement of oxygen and glu-
cose that is named as Oxygen, Glucose Deprivation
(OGD). The OGD experiment in vitro is thought to
mimic the pathological conditions of ischemia. In the
present study, OGD was conducted as described previ-
ously [21] in neurons. OGD solution (pH 7.4) containing
(in mM): 20 NaHCO3, 120 NaCl, 5.36 KCl, 0.33
Na2HPO4, 0.44 KH2PO4, 1.27 CaCl2, 0.81 MgSO4. Was
used. The OGD procedure is just as follows: Neurons were
rinsed twice with OGD solution and were incubated in
OGD solution in a hypoxic incubator (model 3131,
Thermo Forma, San Jose, CA, USA) containing 94 % N2,
1 % O2 and 5 % CO2 for 1 hour; For reoxygenation
(Reox), the neurons were incubated in OGD solution con-
taining 5.5 mM glucose at 37 °C in a humidified 5 % CO2
atmosphere for 24 hours. NaSH (10, 100 and 200 μmol/l)
was continuously administrated from 1 hour before OGD
to the end of the experiment. The same procedure was
carried out in the control neurons except the OGD
treatment.
Bioinformatics analysis of miR-545 target in Ku70
Based on bioinformatics analysis, we predicted that
hsa-miR-30c can bind with the 3’UTR region of Beclin-1
by using four common websites (Target Scan: http://
www.targetscan.org/, miRanda: http://www.microrna.org/,
Microcosm: http://www.ebi.ac.uk/enright- srv/microcosm/
cgi-bin/targets/v5/genome.pl, and PITA: http://genie.weiz-
mann.ac.il/) (Fig. 4a).
Plasmid construction and luciferase reporter assays
For Beclin-1 3’UTR reporter assay, SY-SH-5Y cells were
placed in 24-well plates (1 × 103 cells per well) and then
transfected with either psi-CHECKTM2-WT-BECN-
3’UTR (wild type) or psi- CHECKTM2-MT-BECN-
3’UTR that containing the miR-30c targeting sequence
(UGUUUAC) (mutant) dual Luciferase reporter plasmid
(Promega, WI, USA) according to manufacture’s proto-
col. The mimics and inhibitors of hsa-miR-30c and their
negative controls (RIBO Bio, Guangzhou, P.R. China)
were cotransfected with the reporter plasmids at a final
concentration of 100 nmol/μl. Forty–eight hours after
transfection in neurons, luciferase activity in lysates was
measured with a Dual-Luciferase Reporter Assay System
(Promega, WI, USA) followed by the manufacture’s
suggestions and normalized against the activity of the
pRL-SV40. Firefly and Renilla luciferase activities were
measured using the Dual-Luciferase Reporter Assay
system (Promega, Madison, WI), and the Renilla luciferase
activity was normalized to firefly luciferase activity.
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Independent triplicate experiments were performed for
each plasmid construct.
MTT proliferation assay
SY-SH-5Y cells were seeded at a density of 1000 cells/
well. On the next day, after NaSH (100 μmol/l) treat-
ment for 1 hour, cells were treated with OGD. For cell
viability assay, 50 mL of 5 mg/mL 3–(4,5–Dimethyl-
thiazol–2-yl) 22,5-diphenyltetrazolium bromide (MTT)
was added to wells for 4 h, and then the media were re-
placed with DMSO for analysis of optical density using a
mQuant Microplate Spectrophotometer (BioTek, UK) at
a wavelength of 540 nm. All independent analysis were
run in triplicate.
Cell treatment with miR-30c inhibitor or mimics
SY-SH-5Y cells were treated with pre-miR-30c or anti-30c
(Ambion Pre-miR miRNA Precursors, Life Technologies)
using Oligofectamine (Life Technologies) according to the
manufacturer’s instructions. miRNA mimics negative
control (pre-NC) and anti-miRNA negative control (anti-
NC) were severed as negative controls in the experiments
respectively. Further analysis of the samples (infection or
RNA isolation) was performed at 48 h post-transfection.
Western blot
For analysis of protein expression, western blot assay
was performed. Briefly, both tissues from the injured
spinal cord (extending 2 mm to the infarct, minced with
eye scissors) and cells were homogenized in lysis buffer
(1 % NP–40, 50 mmol/L Tris, pH 7.5, 5 mmol/L EDTA,
1 % SDS, 1 % sodium deoxycholate, 1 % Triton X–100,
1 mmol/L PMSF, 10 mg/ml aprotinin, and 1 mg/ml leu-
peptin) and clarified by centrifuging for 20 min in a
microcentrifuge at 4 °C. respectively. The total protein
concentration was determined with the BCA Protein
Assay Kit and the resulting supernatant (50 mg of protein)
was subjected to SDS-polyacrylamide gel electrophoresis
(PAGE). The separated proteins were transferred to PVDF
(Millipore) followed by blocking with 5 % nonfat milk and
incubated with primary antibody against Beclin–1 (1:500 ),
LC3–I (1:1000), LC3–II (1:1000) or β–actin (1:10000). The
target proteins were captured by anti-rabbit horseradish
peroxidase-conjugated secondary antibody. Finally, protein
was visualized using an enhanced chemiluminescence
system (ECL, Pierce Company, USA).
Statistical analysis
All statistical analyses were performed using SPSS 16.0
software (Chicago, IL). Student’s t test was used to
analyze the significance between the two groups. One-
Fig. 1 The effect of H2S on spinal cord ischemia-reperfusion (I/R) injury in rats. Rats were divided into three groups: sham group, I/R group,
treated with NaHS after I/R group. Rat models of spinal cord ischemia-reperfusion injury were established, which were intraperitoneally injected
with or without 30 μmol/kg NaHS. (a) Serum levels of NaHS were assayed. (b) Basso, Beattie, and Bresnahan (BBB) open-field locomotor scale
test was performed. (c) Quantitative analysis of spinal cord infarction zone. All values are expressed as the mean ± SD. *P < 0.05 vs. sham
group; #P < 0.05 vs. I/R group
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way Analysis of Variance (ANOVA) was used to test the
significance of the Beclin-1 3’UTR. BBB scores data were
analyzed by two factor repeated measures analysis of
variance (ANOVA; for group and time) followed by post
hoc Bonferroni’s test for multiple comparisons. Error
bars represent SD. P-Values < 0.05 were considered
statistically significant.
Results
H2S improved I/R-induced spinal cord injury
To identify the effect of H2S on I/R-induced spinal cord
injury, exogenous NaSH was intraperitoneal injected
into rat models of spinal cord I/R injury 30 minutes
prior to the ischemia. The serum level of H2S was mea-
sured 1 and 6 hours after I/R and the result showed
markedly increased the serum concentration of H2S 6 h
after reperfusion (Fig. 1a). After spinal cord injury, all
the rats were paralyzed in both hindlimbs. Moreover,
they all had urinary and fecal incontinence. The func-
tional recovery score was followed at five time points be-
tween 1 and 48 hours post-I/R injury for both I/R group
and NaHS group with the BBB scoring system, a stand-
ard method for assessing the hind motor function after
SCI in rats. As shown in Fig. 1b, hindlimb locomotor
activity improved gradually with increasing time
throughout the evaluation period, as the BBB scores
gradually increased in both group. Compared to the I/R
group, the NaSH group showed significantly improved
hindlimb activity score from hour 12 after the injury and
on hour 21, the I/R group achieved an average BBB
score of 13.8 with consistent plantar stepping and
forelimb-hindlimb (FL-HL) coordination. After 48 h of
reperfusion, triphenyltetrazolium chloride (TTC) stain-
ing was performed to examine infarct zone in spinal
cord tissues. Quantitative analysis of spinal cord infarct
zone showed that I/R-induced spinal cord injury was ob-
viously improved by NaSH treatment (Fig. 1c).
H2S promoted autophagy in rat model of spinal cord I/R
injury
To explore the mechanisms how H2S could attenuate I/
R-induced spinal cord injury, we examined the expres-
sion of miR-30 profiles by using Quantitative Real-Time
PCR. The result showed no changes in expression of
miR-30 except that decreased in miR-30c (Fig. 2a) sug-
gesting an involvement of miR-30c in neuroprotective
effect against spinal cord ischemia-reperfusion injury of
H2S. LC3 and Beclin-1 are regarded as the autophagy
Fig. 2 Expression of microRNA30 profiles and autophagy-related protein in rats spinal cord. Spinal cord samples were collected from I/R injury
group and its H2S treatment group for molecular detection. (a) Quantitative analysis of expression of miR-30 profiles was determined by using
Quantitative Real-Time PCR. (b) Quantitative analysis of expressions of Beclin-1 mRNA and LC3 mRNA were examined by using Quantitative Real-Time
PCR. (c) Expression of Beclin-1 and LC3-I/II protein were determined by using western blot assay. All values are expressed as the mean ± SD. *P < 0.05
vs. I/R group
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marker and their levels in spinal cord tissue were also
examined. The data showed upregulation in both LC3II
and Beclin-1 expression in levels of miRNA and protein
(Fig. 2b) suggesting that H2S protected spinal cord from
I/R injury via increasing cells autophagy.
H2S improved OGD-induced ischemic injury in SY-SH-5Y
cells
To further investigate the mechanisms involved in H2S
alleviating I/R-induced spinal cord injury, OGD experi-
ment was performed in hippocampal neurons cell line,
SY-SH-5Y. As shown in Fig. 3a, NaSH group showed a sig-
nificantly increase in cell viability compared with OGD
group. Quantitative Real-Time PCR was performed to ex-
amined levels of miR-30c expression and the results
showed declined expression of miR-30c in cells treated
with NaSH (Fig. 3b) which is consistent to that in spinal
cord. Accordingly, expressions of Beclin-1 and LC3 were
also detected. As shown in (Fig. 3c), both miRNA and
protein levels of Beclin-1 and LC3 were significantly
enhanced in NaSH group.
miR-30c acts as a negative regulator of Beclin-1
expression
Recent study showed that miR-30 could impair autopha-
gic process by targeting multiple genes in the autophagy
pathway [22]. Consistently, in our study of the roles of
miR-30 in regulation of autophagy, we observed that
only expression of miR-30c showing around 62 % decrease
during activation of autophagy under I/R injury conditions
in Fig. 2a. Nevertheless, the precise mechanism by which
miR-30c affects autophagic process remains unclear. Be-
cause the mature sequences are highly conserved between
miR-30c and miR-30a, and miR-30a was discovered to act
as a negative regulator of autophagy through altering the
expression of the key autophagy-promoting gene Beclin-1
[22], we thus tested whether miR-30c could also target
Beclin-1 expression. miR-30c is predicted to have the a
consensus sequences within the 3’UTR of Beclin-1
(Fig. 4a), we took advantage of the Beclin-1 dual luciferase
reporter system to study the role of miR-30c in regula-
tion of Beclin-1 expression. As shown in Fig. 4b, co-
transfection of the SY-SH-5Y cells with a pre-miR-30c
(100 nM) led to a significant reduction of the reporter
gene activity, in comparison with the cotransfection
with a control miRNA.
To further demonstrate the effect of miR-30c on
Beclin-1 expression, we transfected SY-SH-5Y cells with
pre-miR-30c, anti-30c or their negative control, and then
examined the expression of Beclin-1 in cells treated with
OGD. Fig. 4c showed that treatment with pre-miR-34c
suppressed Beclin-1 mRNA expression under ischemia,
Fig. 3 Effect of H2S on OGD-induced ischemic injury in SY-SH-5Y cell line. Cell model of OGD injury was established in hippocampal neurons-SY-SH-5Y
cell line, which was injected with or without NaHS (100 μmol/l). (a) Cell viability was analyzed using MTT assay. (b) Quantitative analysis of expression
of miR-30 profiles, (c) Beclin-1 mRNA and LC3 mRNA were examined by using Quantitative Real-Time PCR. (d) Expression of Beclin-1 and LC3-
I/II protein were determined by using western blot assay. All values are expressed as the mean ± SD. *P < 0.05 vs. OGD group
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however, that was increased by cells treated with anti-
30c under both ischemia and normoxia. Additionally, we
attempted to detected the possible regulated LC3 by
miR-30c and the result showed that the LC3 expression
varied as Beclin-1 (Fig. 4d) indicating the key regulated
role of miR-30c in OGD-induced cells autophagy.
S2H inhibited Beclin-1 3’UTR under OGD
To ascertain the role of miR-30c in protective effect of H2S
in autophagy, cells were pretreated NaSH at dose of 10, 100
and 200 μmol/L before OGD treatment and Beclin-1
3’UTR activity was examined. The result showed that
NaSH treatment significantly reduced the reporter gene
activity in a dose dependent (Fig. 5).
Spinal core protective effect of H2S was reversed by
miR-30c overexpression
Experiments in SY-SH-5Y cells demonstrated that miR-
30c played an important role in H2S-induced autophagy
after OGD injury. To assess the effect of miR-30c on the
activation of cells autophagy in ischemic spinal cord, BBB
scores and infarct zone were detected after reperfusion in
rat spinal cord injected with pre-miR-30c or 3-MA, an in-
hibitor for antophagy. Fig. 6a showed that H2S-induced
improvement of hindlimb locomotor activity was reversed
by spinal cord treated with pre-miR-30c or 3-MA grad-
ually with increasing time throughout the evaluation
period, as the BBB scores gradually decreased in both
groups. Additionally, quantitative analysis of spinal cord
infarction zone showed that H2S induced-alleviation of I/
R spinal cord injury was also obviously abrogated by spinal
cord treated with pre-miR-30c or 3-MA (Fig. 6b).
Discussion
Spinal cord ischemia/reperfusion injury, which occur in
secondary neuronal injury after I/R spinal cord injury, is
considered as a major health problem that is a frequent
cause of disability and death and makes considerable
Fig. 4 Targeting site of miR-30c in the Beclin-1 3’UTR. (a) Beclin-1 3’UTR was predicted a binding site for hsa-miR-30c. The highly conserved
mature miR-30c sequence and potential binding between the miR-30c seed region to the mouse Beclin-1 3’UTR sequence are shown. 24 h after
transfected with pre-miR-30c or anti-30c, SY-SH-5Y cells were lyzed to analyze (b) Beclin-1 3’UTR activity by using luciferase report assay, (c)
Beclin-1 mRNA and (d) LC3 mRNA by using Quantitative Real-Time PCR. All values are expressed as the mean ± SD. *P < 0.05 vs. normoxia
negative control group; #P < 0.05 vs. ischemic negative control group
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demands on health services. Nevertheless, there was
limited advance in the therapeutic strategies to counter
spinal cord injury. Thus, neuroprotection and neurore-
covery are still the main therapeutic strategies under
development. An ideal neuroprotectant would be non-
toxic, easily administered, and offer protection at all
stages of injury, including prophylaxis. In this study, we
exogenously treated spinal cord I/R injury rat with
H2S, which acted as a novel signaling molecule in cen-
tral nervous system [23], by injected with NaSH, and
examined the function of spinal cord after injury. Our
results showed that NaSH treatment improved the hide
motor function and infarct zone in rat model of spinal
cord I/R injury. The underlying mechanism is that ad-
ministration of H2S activates autophagy that indicated
by upregulation the expression of autophagy-related
proteins including Beclin-1 and LC3II via inhibiting
miR-30c expression after spinal cord reperfusion injury.
The time profile of BBB scoring system for hindlimb
locomotor function after I/R injury was determined, and
time effects of H2S were detected in this study. We ob-
served that pretreatment of NaHS 30 min before I/R
injury can alleviate I/R induced spinal cord injury in a
manner of time dependent from hour 6 h to hour 48.
In fact, previous studies demonstrated that pathological
development of I/R results in neuronal cell death [24].
Therefor, after 48 h I/R, measurement of infarct zone
was performed in spinal cord tissues. We found in the
present study that I/R obviously increased infarct zone
that was effectively ameliorated by pretreatment 30 min
before I/R injury by NaHS suggesting reducing I/R-in-
duced neural cell lost may be contributed to the neu-
roprotective effects of H2S. These results was further
demonstrated by result that H2S function as a neuro-
protective factor for hippocampal neurons that treated
by OGD. These findings indicate that H2S may be a
potential therapy for spinal cord I/R injury.
Increased autophagy is observed in multiple and distinct
experimental models of spinal cord injury [16, 25]. Au-
tophagy plays an important roles in the stability of the
body metabolism via affecting the mechanism of apoptosis
as well as autophagic cell death. Previous sthudy showed
that autophagy is important for the balance between pro-
tein synthesis and degradation in spinal cord injury [26].
For example, in cases in which mitochondria are exten-
sively damaged, autophagy may be protective by seques-
tering and degrading defective mitochondria before they
can release death-inducing proteins [27]. Notably, in the
early nerve damage, including I/R injury autophagy
process is activated to protect nerve cell against injury
[28]. This is also observed in our present study. The result
of NaSH treatment obviously promoting expression of the
LC3II and Beclin-1 which acted as markers for autophagy
suggested that H2S protect spinal cord against I/R injury
via increased neurocyte autophagy. It was supported by re-
sult of inhibition of autophagy by 3-MA abrogated H2S
functional outcome after I/R injury in rats.
In addition, we confirmed and are the first to note that
the miR-30c was downregulated during spinal cord pro-
tective effect of H2S in I/R injury. Previously, several
microRNAs have also been reported to be involved in au-
tophagy modulation by regulating the expression of
autophagy-related genes [29, 30]. Recent study showed
that miR-30 could impair autophagic process by targeting
multiple genes in the autophagy pathway [27] . Thus, we
hypothesized that there exists the possible targeting region
of Beclin-1 mRNA by miR-30c, and it was supported by
the result of bioinformatics analysis in Fig. 4a. To con-
firm this cellular metabolism, hippocampal neurons
was transfected with pre-miR-30c or anti-30c to exam-
ined expression of Beclin-1. The data indicated the
negative regulation of miRNA or protein expression of
Beclin-1 by miR-30c.
Conclusion
The present study demonstrates that systemic administra-
tion of H2S improved spinal cord injury and motor func-
tion in rat model of I/R injury. H2S may serve as a
neuroprotectant to treat I/R-induced spinal cord injury via
activating autophagy in a miR-30c dependent signaling
pathway. This founding might has potential clinical thera-
peutic value for treatment of spinal cord injury.
Fig. 5 Effect of H2S on Beclin-1 3’UTR activity under the condition of
ischemic. One hour after SY-SH-5Y cells treated with 10, 100, 200 μmol/l
NaHS, cell model of OGD injury was established in hippocampal
neurons-SY-SH-5Y cell line. Beclin-1 3’UTR activity was examined by
using luciferase report assay. All values are expressed as the mean ± SD.
*P < 0.05 vs. cells treated without NaHS
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